Literature DB >> 6206889

Monoclonal antibodies against the lac carrier protein from Escherichia coli. 2. Binding studies with membrane vesicles and proteoliposomes reconstituted with purified lac carrier protein.

D Herzlinger, P Viitanen, N Carrasco, H R Kaback.   

Abstract

Monoclonal antibodies 4B1 and 5F7 bind to distinct, nonoverlapping epitopes in the lac carrier protein. By use of immunofluorescence microscopy and radiolabeled monoclonal antibodies and Fab fragments, it is shown that both 4B1 and 5F7 bind to spheroplasts and to right-side-out vesicles, but only to a small extent to inside-out vesicles. Clearly, therefore, the lac carrier protein has an asymmetric orientation within the cytoplasmic membrane of Escherichia coli, and both epitopes are located on the periplasmic surface. In right-side-out vesicles, radiolabeled 4B1 binds with a stoichiometry of 1 mol of antibody per 2 mol of lac carrier protein, while radiolabeled 4B1 Fab fragments bind 1:1. Importantly, the intact antibody and its Fab fragments bind to proteoliposomes reconstituted with purified lac carrier protein with a stoichiometry very similar to that observed in right-side-out membrane vesicles. Thus, it seems highly likely that the orientation of the lac carrier protein in the reconstituted system is similar to that in the bacterial cytoplasmic membrane, at least with respect to 4B1 epitope.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206889     DOI: 10.1021/bi00311a018

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  Functional interactions between putative intramembrane charged residues in the lactose permease of Escherichia coli.

Authors:  M Sahin-Tóth; R L Dunten; A Gonzalez; H R Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  Insertional mutagenesis of hydrophilic domains in the lactose permease of Escherichia coli.

Authors:  E McKenna; D Hardy; H R Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

3.  Functional complementation of internal deletion mutants in the lactose permease of Escherichia coli.

Authors:  E Bibi; H R Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

4.  Reconstitution of an active lactose carrier in vivo by simultaneous synthesis of two complementary protein fragments.

Authors:  W Wrubel; U Stochaj; U Sonnewald; C Theres; R Ehring
Journal:  J Bacteriol       Date:  1990-09       Impact factor: 3.490

5.  Sequential truncation of the lactose permease over a three-amino acid sequence near the carboxyl terminus leads to progressive loss of activity and stability.

Authors:  E McKenna; D Hardy; J C Pastore; H R Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

6.  A five-residue sequence near the carboxyl terminus of the polytopic membrane protein lac permease is required for stability within the membrane.

Authors:  P D Roepe; R I Zbar; H K Sarkar; H R Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  Electrophysiological characterization of LacY.

Authors:  Juan J Garcia-Celma; Irina N Smirnova; H Ronald Kaback; Klaus Fendler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

8.  Organization and stability of a polytopic membrane protein: deletion analysis of the lactose permease of Escherichia coli.

Authors:  E Bibi; G Verner; C Y Chang; H R Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

9.  Design of a membrane transport protein for fluorescence spectroscopy.

Authors:  M E Menezes; P D Roepe; H R Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

10.  Properties of permease dimer, a fusion protein containing two lactose permease molecules from Escherichia coli.

Authors:  M Sahin-Tóth; M C Lawrence; H R Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.